AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases

October 15, 2025

Acumen and JCR Forge $555M Alzheimer’s Deal Using Blood-Brain Barrier Technology

July 17, 2025

AstraZeneca and Alvogen penalized for collusion drug agreement in Korea

October 21, 2022

Must Read

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

May 12, 2026

Can AI Reduce Drug Development Costs Without Increasing Risk?

May 12, 2026

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

May 12, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Can AI Reduce Drug Development Costs Without Increasing Risk?

Top 10 Skills Every Life Sciences Professional Needs in 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Clinical

Eisai and Biogen Start Rolling Submissions with the FDA for Their Infused Alzheimer’s Drug Leqembi

Editor Picks

AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases

Acumen and JCR Forge $555M Alzheimer’s Deal Using Blood-Brain Barrier Technology

AstraZeneca and Alvogen penalized for collusion drug agreement in Korea

Must Read

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Can AI Reduce Drug Development Costs Without Increasing Risk?

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

Hot Topics

About Us

Follow Us